ReviewChinese medical journal2026
Integrating multimodal intelligence in heart failure: AI-driven risk prediction, precision diagnosis, phenotyping, personalized treatment, and prognosis.
Review in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- From assistance to autonomy: AI agent systems in cardiovascular medicine-a review of paradigms, architectures, and clinical translation.Frontiers in cardiovascular medicine · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractHeart failure (HF) is a chronic condition characterized by high morbidity and mortality worldwide, imposing a substantial burden on healthcare systems. In recent years, artificial intelligence (AI) technologies, including machine learning, deep learning, and large language models, have demonstrated great potential in HF management. By integrating multimodal data, such as electronic health records and medical imaging, AI models address limitations in risk prediction, phenotyping, diagnosis, treatment, and prognosis, offering novel insights to improve the quality of life for HF patients. However, several challenges remain before AI can be reliably implemented in clinical practice, including model selection, model generalization, interpretability, and limited reliability in real-world settings. In this review, we systematically summarize recent advances in application of AI in HF management across multiple domains, including inspection, monitoring, treatment, and integration. We further discuss key real-world challenges to implementation, and outline future directions for the development of intelligent HF management. In addition, representative application cases are presented to illustrate how AI technologies can be developed and translated into clinical practice, with the aim of providing practical insights and methodological guidance for researchers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.